Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma. Issue 3 (March 2020)
- Record Type:
- Journal Article
- Title:
- Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma. Issue 3 (March 2020)
- Main Title:
- Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma
- Authors:
- Hu, Bingxin
Xiao, Jie
Xiu, Yan
Fu, Zhequan
Shi, Hongcheng
Cheng, Dengfeng - Abstract:
- Abstract : Objective: The uptake of 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/computed tomography (CT) is known to be linked to programmed death ligand 1 (PD-L1) expression on tumor cells (TC). However, the association between PD-L1 expression on immune cells (IC) and 18 F-FDG accumulation is still unclear. Here, we conducted a clinicopathological study to investigate the relationship between PD-L1 expression on TC/IC and 18 F-FDG uptake in patients with surgically resected pulmonary adenocarcinoma (ADC). Methods: A total of 450 ADC patients who underwent preoperative 18 F-FDG-PET/CT imaging were analyzed retrospectively. Immunohistochemistry analysis was performed for PD-L1 expression on TC and IC in ADC specimens with SP142. PD-L1 expression was performed on whole-tissue sections and given scores (0/1/2/3) according to percent of PD-L1 + cells in TC and IC. Results: Compared to TC0 and IC0, PD-L1 positive expression was 90.4% (407/450) in ADC specimens. Both PD-L1 expression score on TC and IC were associated with maximum standardized uptake (SUVmax). SUVmax augmented with increasing PD-L1 expression (TC0 and IC0, 4.3 ± 3.4; TC or IC1/2/3, 7.7 ± 5.6; TC or IC2/3, 8.1 ± 5.6; TC or IC3, 8.4 ± 5.4). The best cut-off value of PD-L1 expression, determined by receiver operating characteristic curve, was 5.1 for TC or IC1/2/3 [area under the curve (AUC) = 0.713, sensitivity 62.2%, specificity 72.1%]. Multivariate analysis demonstrated that TC or IC1/2/3 subset was correlated withAbstract : Objective: The uptake of 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/computed tomography (CT) is known to be linked to programmed death ligand 1 (PD-L1) expression on tumor cells (TC). However, the association between PD-L1 expression on immune cells (IC) and 18 F-FDG accumulation is still unclear. Here, we conducted a clinicopathological study to investigate the relationship between PD-L1 expression on TC/IC and 18 F-FDG uptake in patients with surgically resected pulmonary adenocarcinoma (ADC). Methods: A total of 450 ADC patients who underwent preoperative 18 F-FDG-PET/CT imaging were analyzed retrospectively. Immunohistochemistry analysis was performed for PD-L1 expression on TC and IC in ADC specimens with SP142. PD-L1 expression was performed on whole-tissue sections and given scores (0/1/2/3) according to percent of PD-L1 + cells in TC and IC. Results: Compared to TC0 and IC0, PD-L1 positive expression was 90.4% (407/450) in ADC specimens. Both PD-L1 expression score on TC and IC were associated with maximum standardized uptake (SUVmax). SUVmax augmented with increasing PD-L1 expression (TC0 and IC0, 4.3 ± 3.4; TC or IC1/2/3, 7.7 ± 5.6; TC or IC2/3, 8.1 ± 5.6; TC or IC3, 8.4 ± 5.4). The best cut-off value of PD-L1 expression, determined by receiver operating characteristic curve, was 5.1 for TC or IC1/2/3 [area under the curve (AUC) = 0.713, sensitivity 62.2%, specificity 72.1%]. Multivariate analysis demonstrated that TC or IC1/2/3 subset was correlated with histological subtype, PD-1 expression on IC and SUVmax. Conclusion: High SUVmax is associated with PD-L1 expression on TC and IC in surgically resected pulmonary ADC. 18 F-FDG-PET/CT imaging can be a potential tool to evaluate PD-L1 expression in pulmonary ADC. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 41:Issue 3(2020)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 41:Issue 3(2020)
- Issue Display:
- Volume 41, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 41
- Issue:
- 3
- Issue Sort Value:
- 2020-0041-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-03
- Subjects:
- immune cells -- PET/computed tomography -- programmed cell death-ligand 1 -- pulmonary adenocarcinoma -- tumor cells
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000001136 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13735.xml